High-dose cyclophosphamide therapy for malignant disease.Toxicity, tumor response, and the effects of stored autologous marrow
Open Access
- 1 February 1972
- Vol. 29 (2) , 357-365
- https://doi.org/10.1002/1097-0142(197202)29:2<357::aid-cncr2820290215>3.0.co;2-m
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Low temperature preservation of monkey marrow in dimethyl sulfoxideCryobiology, 1970
- Effect of large intermittent intravenous doses of cyclophosphamide in lymphomaCancer, 1970
- BONE-MARROW TRANSPLANTATION IN A PATIENT WITH THE WISKOTT-ALDRICH SYNDROMEThe Lancet, 1968
- The African lymphoma:Preliminary observations on response to therapyCancer, 1965
- Isogeneic Marrow Infusion Following Nitrogen Mustard in the Dog.Experimental Biology and Medicine, 1965
- The Clinical Application of Bone Marrow GraftingBritish Journal of Cancer, 1962
- Autologous and Isologous Bone Marrow Storage and Infusion in the Treatment of Myelo-SuppressionTransfusion, 1962
- Meaningful clinical classification of therapeutic responses to anticancer drugsClinical Pharmacology & Therapeutics, 1961
- NITROGEN-MUSTARD THERAPY COMBINED WITH AUTOLOGOUS MARROW INFUSIONThe Lancet, 1961
- Clinical evaluation of a new alkylating agent: Cytoxan (cyclophosphamide)Cancer, 1960